Journal of Clinical Oncology

Reply to: Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy

N Nadine M. Tung (Nadine M. Tung, MD, FASCO, Dana-Farber Cancer Institute, Boston, MA; Tianyu Li, MS, Dana-Farber Cancer Institute, Boston, MA; and Judy E. Garber, MD, MPH, Dana-Farber Cancer Institute, Boston, MA) T Tianyu Li J Judy E. Garber (Nadine M. Tung, MD, FASCO, Dana-Farber Cancer Institute, Boston, MA; Tianyu Li, MS, Dana-Farber Cancer Institute, Boston, MA; and Judy E. Garber, MD, MPH, Dana-Farber Cancer Institute, Boston, MA)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 07, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

N

Nadine M. Tung

Nadine M. Tung, MD, FASCO, Dana-Farber Cancer Institute, Boston, MA; Tianyu Li, MS, Dana-Farber Cancer Institute, Boston, MA; and Judy E. Garber, MD, MPH, Dana-Farber Cancer Institute, Boston, MA

T

Tianyu Li

J

Judy E. Garber

Nadine M. Tung, MD, FASCO, Dana-Farber Cancer Institute, Boston, MA; Tianyu Li, MS, Dana-Farber Cancer Institute, Boston, MA; and Judy E. Garber, MD, MPH, Dana-Farber Cancer Institute, Boston, MA

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001